WESTWATER RESOURCES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WESTWATER RESOURCES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 14, 2020 |
| FY2011 | Dec 31, 2009 | $4.67M | Mar 12, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($27.33M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($12.66M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($7.75M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($11.12M) | Mar 19, 2024 |
| FY2019 | Dec 31, 2019 | ($10.57M) | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | ($35.68M) | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | ($19.29M) | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | ($19.61M) | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | ($15.14M) | Mar 2, 2017 |
| FY2015 | Sep 30, 2015 | $300.0K | Mar 18, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | ($11.24M) | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | ($6.29M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($36.05M) | Feb 14, 2020 |
| FY2013 | Dec 31, 2013 | ($19.85M) | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | ($19.57M) | Mar 27, 2014 |
| FY2012 | Sep 30, 2012 | ($5.20M) | Dec 17, 2013 |
| FY2012 | Jun 30, 2012 | ($5.36M) | Dec 17, 2013 |
| FY2012 | Mar 31, 2012 | ($4.30M) | Dec 17, 2013 |
| FY2012 | Dec 31, 2011 | ($11.24M) | Dec 17, 2013 |
| FY2012 | Sep 30, 2011 | ($2.87M) | Dec 17, 2013 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.18M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.94M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.15M | Mar 19, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.90M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($5.81M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($11.43M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($13.18M) | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | ($16.92M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($15.18M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | ($10.05M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($11.65M) | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | ($11.60M) | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | ($12.31M) | Mar 1, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $100.0K | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $26.0K | Mar 1, 2018 |
| FY2013 | Dec 31, 2013 | $173.6K | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | $1.28M | Mar 27, 2014 |
| FY2012 | Sep 30, 2012 | $1.13M | Dec 17, 2013 |
| FY2012 | Jun 30, 2012 | $978.9K | Dec 17, 2013 |
| FY2012 | Mar 31, 2012 | $361.4K | Dec 17, 2013 |
| FY2012 | Dec 31, 2011 | $455.9K | Dec 17, 2013 |
| FY2012 | Sep 30, 2011 | $291.8K | Dec 17, 2013 |
| FY2012 | Jun 30, 2011 | $224.9K | Dec 17, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.53M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $146.36M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $149.83M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $168.41M | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | $132.98M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $61.94M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $26.98M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $29.96M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $50.24M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $56.91M | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.00M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $13.24M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $9.39M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $26.44M | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | $6.79M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $4.47M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $9.92M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $9.17M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $9.12M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $13.87M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $181.53M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $133.12M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $140.44M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | $141.97M | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | $126.20M | Mar 19, 2024 |
| FY2022 | Dec 31, 2020 | $57.47M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $17.06M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $20.79M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $41.12M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $43.05M | Feb 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($401.01M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($373.69M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($361.03M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($353.28M) | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | ($342.16M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($326.01M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | ($302.44M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($291.87M) | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | ($256.19M) | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | ($236.90M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.58M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.27M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $10.85M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $75.20M | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | $115.29M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $50.32M | Feb 11, 2022 |
| FY2019 | Jan 31, 2020 | $1.60M | Feb 14, 2020 |
| FY2020 | Dec 31, 2019 | $1.87M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.58M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.05M | Feb 15, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Feb 11, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Feb 11, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 117.99M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 64.83M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 55.39M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 48.41M | Mar 19, 2024 |
| FY2022 | Dec 31, 2021 | 35.28M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | 19.17M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 3.34M | Feb 16, 2021 |
| FY2019 | Apr 22, 2019 | 1.50M | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | 1.44M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 27.78M | Feb 15, 2019 |